Dean Maccarter

US Patent:

6858006, Feb 22, 2005

Filed:

Sep 7, 2001

Appl. No.:

09/948997

Inventors:

Dean J. MacCarter - Englewood CO, US
Andreas N. Hadjicostis - Lone Tree CO, US
John K. Buckner - Littleton CO, US

Assignee:

Wireless Medical, Inc. - Englewood CO

International Classification:

A61B005/00

US Classification:

600300, 600301, 600538, 128903, 128904, 128920

Abstract:

According to the invention, a system for monitoring health information of a plurality of patients is disclosed. Included in the system are a data gathering device, a node, a wide area network, and a monitoring center. The data gathering device includes a respiration sensor, a wireless transmitter, and a self-contained power source. The node is wirelessly coupled to the data gathering device and the wide area network is coupled to the node. Located remote to the node, the monitoring center is coupled to the wide area network.

US Patent:

20050277598, Dec 15, 2005

Filed:

Apr 29, 2005

Appl. No.:

11/118613

Inventors:

Dean MacCarter - Englewood CO, US
John St.Cyr - Coon Rapids MN, US

International Classification:

A61K031/70

US Classification:

514023000

Abstract:

A method for improving ventilatory efficiency, comprising the administration of a pentose is disclosed. The most preferred pentose is D-ribose, to be administered in a dosage of from two to ten grams, one to four times daily for at least a week, but most preferably long term.

US Patent:

20100099630, Apr 22, 2010

Filed:

Dec 15, 2006

Appl. No.:

11/639476

Inventors:

Dean J. MacCarter - Englewood CO, US
John A. St. Cyr - Coon Rapids MN, US

International Classification:

A61K 31/7004
A61P 11/00

US Classification:

514 23

Abstract:

This invention is a method of improving the function of the pulmonary arm of the cardiac-pulmonary axis by the administration of a pharmaceutical or nutritional supplement to a patient in which the function of the pulmonary arm is suboptimal, but not as a sequella of dysfunction of the cardiac arm. The exemplar patient is one suffering from chronic obstructive pulmonary disease. The preferred pentose is D-ribose, to be administered chronically.

US Patent:

58171347, Oct 6, 1998

Filed:

Feb 25, 1997

Appl. No.:

8/805769

Inventors:

Saul E. Greenhut - Aurora CO
Dean J. MacCarter - Englewood CO

International Classification:

A61N 1362

US Classification:

607 14

Abstract:

In an implantable cardiac device, atrial signals, spaced either spatially or temporally, are sensed and stored. The morphology of the signals are compared and an atrial fibrillation indication is generated if the signals are different. The device then either changes its mode of operation or applies appropriate therapy.

US Patent:

54877539, Jan 30, 1996

Filed:

Mar 16, 1995

Appl. No.:

8/405507

Inventors:

Dean J. MacCarter - Englewood CO
Don Hopper - Denver CO
Daniel Cooper - Lakewood CO
Roger Hassell - Golden CO

Assignee:

Telectronics Pacing Systems, Inc. - Englewood CO

International Classification:

A61N 1365

US Classification:

607017

Abstract:

A rate responsive pacemaker measures a metabolic demand parameter of a patient. The metabolic demand parameter is converted to a corresponding metabolic indicated rate which determines the pulse rate of the pacer. The converting is based on a profile dependent on the predicted anaerobic threshold level of the patient, as well as his or her age and physical fitness.

US Patent:

57921962, Aug 11, 1998

Filed:

Mar 24, 1997

Appl. No.:

8/823077

Inventors:

Daniel Cooper - 67500 Hauguenau, FR
Dean J. MacCarter - Englewood CO

International Classification:

A01N 136

US Classification:

607 17

Abstract:

A rate responsive pacemaker senses an instantaneous metabolic indicative parameter such as minute volume and monitors this parameter over an extended time period of 30 days. A corresponding cumulative rate control parameter is generated. The cumulative rate parameter is converted into a metabolic pulsing rate for generating pulses in accordance with a set of physical activity parameters.

US Patent:

20180296127, Oct 18, 2018

Filed:

Jun 18, 2018

Appl. No.:

16/011627

Inventors:

- St. Paul MN, US
Dean J. MACCARTER - Englewood CO, US
David M. ANDERSON - White Bear Lake MN, US
Andrew HOFMEISTER - Moraga CA, US

International Classification:

A61B 5/08
A61B 5/083
A61B 5/091
A61B 5/00
A61B 5/087

Abstract:

Systems and methods for quantifying the likelihood of the contribution of multiple possible forms of chronic disease to patient reported dyspnea can include the testing protocol having a flow/volume loop, performed at rest, flowed by the measurement of cardiopulmonary exercise gas exchange variables during rest, exercise and recovery as unique data sets. The data sets are analyzed using feature extraction steps to produce a pictorial image consisting of disease silos displaying the likelihood of the contribution of various chronic diseases to patient reported dyspnea. In some embodiments, the silos are split into subclass silos. In some embodiments, multiple chronic disease indexes are used to differentiate between sub-types of a particular chronic disease (e.g., differentiating WHO 1 PH from WHO 2 or WHO 3 PH). Test results are plotted serially to asses to provide feedback to the physician on the efficacy of therapy provided to the patient.

US Patent:

20160317561, Nov 3, 2016

Filed:

Jul 12, 2016

Appl. No.:

15/208306

Inventors:

- Ham Lake MN, US
Dean J. MacCarter - Englewood CO, US

International Classification:

A61K 31/7004
A61K 9/00

Abstract:

Low doses of D-ribose raise the level of fitness and lower the perception of fatigue in baby boomers aged 45-65 who perceive themselves as fatigued. The doses range from 0.100 grams to 3.0 grams, bid, for a total of 0.200 to 6.0 grams daily. Objective measures of cardiopulmonary parameters confirm the improvement of fitness and questionnaires confirm that quality of life and mental states are improved with D-ribose administration.